Posted Sep 2, 2026

[Remote] VP, Clinical Research, Parkinsons

Apply Now

Note: The job is a remote job and is open to candidates in USA. Sumitomo Pharma America, Inc. is a global pharmaceutical company focused on developing novel therapies across oncology, rare diseases, cell and gene therapies, and central nervous system disorders. The Vice President will lead clinical development strategies and scientific oversight for Parkinson’s disease, movement disorders, stem cell therapies, and CNS pipeline assets from proof of concept through regulatory submissions and approval. The role also oversees clinical research execution, regulatory compliance, portfolio optimization, stakeholder collaboration, and team leadership.


Responsibilities


Skills


Benefits


Company Overview

  • Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and CNS. It was founded in 2023, and is headquartered in Marlborough, Massachusetts, US, with a workforce of 1001-5000 employees. Its website is .

  • Company H1B Sponsorship

  • Sumitomo Pharma America, Inc. has a track record of offering H1B sponsorships, with 6 in 2026, 8 in 2025, 9 in 2024, 14 in 2023. Please note that this does not guarantee sponsorship for this specific role.

  •